| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Revenue | $433K | -57.3% |
| Cost of Revenue | $2.3M | -24.4% |
| R&D Expense | $5.7M | -48.7% |
| SG&A Expense | $7.9M | -28.2% |
| Operating Income | -$15.5M | +36.0% |
| Interest Expense | $3.0M | — |
| Pre-tax Income | -$18.3M | — |
| Net Income | -$18.3M | +22.9% |
| EPS (Basic) | -$21.79 | -453.0% |
| EPS (Diluted) | -$21.79 | -453.0% |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $2.8M | -64.2% |
| Inventory | $1.8M | -13.7% |
| Current Assets | $5.0M | -52.0% |
| Total Assets | $5.6M | -50.5% |
| Current Liabilities | $8.8M | +155.6% |
| Total Liabilities | $9.1M | +128.9% |
| Stockholders' Equity | -$3.5M | -147.2% |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$11.3M | +50.0% |
| Capital Expenditures | $8K | +0.0% |
| Investing Cash Flow | -$8K | +0.0% |
| Financing Cash Flow | $6.2M | -74.5% |
| Free Cash Flow | -$11.3M | +50.0% |